A new partnership with Neurim Pharmaceuticals Ltd.
Ähnliche Neuigkeiten
Medis and PAION Have Signed Commercialization Agreement for Three Innovative Hospital Therapies
Medis will be an exclusive partner for the commercialization of three innovative products in 9 different markets across the CEE region.
Lesen Sie mehr
Medis Proudly Announces a New Partnership with Biocodex Nordics
Exclusive distribution agreement for Medis’ latest development Ladiva, which will be commercialized by Biocodex Nordics in Finland, represents a new important...
Lesen Sie mehr